Rejuvenix™ is an advanced skin research complex that combines GHK-Cu (Copper Tripeptide-1) with Hyaluronic Acid, bringing together two of the most extensively studied ingredients in regenerative and cosmetic research. This premium formulation is designed to support investigations into skin renewal, extracellular matrix integrity, collagen production, hydration, and overall skin appearance.
GHK-Cu is a naturally occurring copper-binding tripeptide with the molecular formula C₁₄H₂₄CuN₆O₄ and a molecular weight of approximately 340.9 g/mol. First identified in human plasma, GHK-Cu has been widely studied for its role as a biological signaling peptide involved in tissue remodeling and wound repair. Research suggests it may influence the expression of numerous genes associated with collagen synthesis, elastin production, antioxidant defense, and the maintenance of healthy connective tissue.
Hyaluronic Acid is a naturally occurring glycosaminoglycan found throughout the skin and connective tissues, where it plays a critical role in maintaining hydration and structural integrity. Due to its exceptional water-binding capacity, Hyaluronic Acid has become one of the most researched compounds for improving skin moisture, elasticity, and overall appearance while supporting the extracellular matrix.
Together, GHK-Cu and Hyaluronic Acid create a complementary research formulation that targets both the biological signaling pathways involved in skin regeneration and the hydration necessary for maintaining healthy tissue architecture.
Every batch of Rejuvenix™ is manufactured to stringent quality standards and undergoes independent third-party purity testing to ensure consistency, identity, and research-grade quality.
For laboratory research use only. Not intended for human consumption or therapeutic use.
No certificate available for this product.
In Stock
Don’t lose your saved cart. Enter your email below so your research items are ready whenever you return.
Before entering this website, please read and agree
to the following statement:
You are not old enough to view this content.